
Mainstay Medical Announces Receipt of European and Australian Approvals of MRI Labeling on ReActiv8® Restorative Neurostimulation System™
Published on July 9, 2024
MRI clearances received in connection with certification of conformity with EU and UK Medical Device Regulations DUBLIN, July 9, 2024–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced that it has received regulatory approvals in the European Union, the United Kingdom and Australia for full-body MR conditional labeling for the ReActiv8® Restorative Neurostimulation system. As a result, …
The post Mainstay Medical Announces Receipt of European and Australian Approvals of MRI Labeling on ReActiv8® Restorative Neurostimulation System™ appeared first on Ortho Spine News.
